American Society of Hematology
Explore special articles published online first to coincide with presentations at American Society of Hematology.
Related Articles
Tezepelumab Fails Study Endpoint of Reducing Moderate-to-Severe COPD Exacerbations
However, subgroup analyses may reveal a more pronounced effect in people with severe COPD.
Revolutionizing Tech Strategy: Informa TechTarget’s Merger and Its Impact on Digital Engagement
Podcast Episode · What’s Up with Tech? · 01/23/2025 · 26m
Certain Meds and Diet Can Reverse Type 2 Diabetes
FRIDAY, Jan. 24, 2025 (HealthDay News) — People can reverse their type 2 diabetes through a combination of calorie cutting and medication, a small clinical…
Relationship of modifiable risk factors with the incidence of thyroid cancer: a worldwide study – BMC Research Notes
Background Thyroid cancer is one of the most common cancers of the endocrine system. The incidence of this cancer has increased in many countries. Many…
Structure-guided discovery of viral proteins that inhibit host immunity
Large-scale, structure-guided computational pipeline sifts through millions of phage proteins to identify those that bind and antagonize host immune proteins. Detected proteins are shown to…
GLP-1RA Use and Thyroid Cancer Risk
This secondary analysis of a target trial emulation of a comparative effectiveness study uses claims data to estimate the risk of incident thyroid cancer in…
Minnesota lacks data in assisted-living deaths due to maltreatment
No one has tracked total nursing home and assisted-living maltreatment deaths in Minnesota until a local advocacy group started analyzing the data.
Revolutionizing Enterprise AI: SmythOS on Seamless Integration, Practical Use Cases, and Educational Empowerment
Interested in being a guest? Email us at admin@evankirstel.comImagine a world where AI seamlessly integrates with your everyday business tools, making complex w
Alberta releases secret report into the province’s COVID response
The $2-million task force’s final report touched on several points common with disinformation campaigns such as the effectiveness of public health restrictions and masking
Philips’ Shez Partovi on the challenges of AI in medical devices
Philips’ Shez Partovi said a lot of the company’s focus is working to determine how AI can be used to give time back to clinicians.
